Cargando…

Wnt5a causes ROR1 to complex and activate cortactin to enhance migration of chronic lymphocytic leukemia cells

Chronic lymphocytic leukemia cells (CLL) migrate between the blood and lymphoid tissues in response to chemokines. Such migration requires structured cytoskeletal-actin polymerization, which may involve the protein cortactin. We discovered that treatment of CLL cells with Wnt5a causes Receptor tyosi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hasan, Md Kamrul, Rassenti, Laura, Widhopf, George F., Yu, Jian, Kipps, Thomas J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6462876/ https://www.ncbi.nlm.nih.gov/pubmed/30568170 http://dx.doi.org/10.1038/s41375-018-0306-7

Ejemplares similares

Wnt5a induces ROR1 to recruit cortactin to promote breast-cancer migration and metastasis
por: Hasan, Md Kamrul, et al.
Publicado: (2019)

Wnt5a enhances proliferation of chronic lymphocytic leukemia and ERK1/2 phosphorylation via a ROR1/DOCK2-dependent mechanism
por: Hasan, Md Kamrul, et al.
Publicado: (2020)

Wnt5a induces ROR1 to complex with HS1 to enhance migration of chronic lymphocytic leukemia cells
por: Hasan, M K, et al.
Publicado: (2017)

Impact of cortactin in cancer progression on Wnt5a/ROR1 signaling pathway
por: Hasan, Kamrul, et al.
Publicado: (2023)

High expression level of ROR1 and ROR1-signaling associates with venetoclax resistance in chronic lymphocytic leukemia
por: Ghia, Emanuela M., et al.
Publicado: (2022)

Wnt5a induces ROR1 to associate with 14-3-3ζ for enhanced chemotaxis and proliferation of chronic lymphocytic leukemia cells
por: Yu, J, et al.
Publicado: (2017)

Cirmtuzumab inhibits Wnt5a-induced Rac1 activation in chronic lymphocytic leukemia treated with ibrutinib
por: Yu, J, et al.
Publicado: (2017)

Cirmtuzumab inhibits ibrutinib-resistant, Wnt5a-induced Rac1 activation and proliferation in mantle cell lymphoma
por: Yu, Jian, et al.
Publicado: (2018)

Lack of Allelic Exclusion in B Cell Chronic Lymphocytic Leukemia
por: Rassenti, Laura Z., et al.
Publicado: (1997)

Cortactin in cancer cell migration and invasion
por: Yin, Miao, et al.
Publicado: (2017)

ROR1: an orphan becomes apparent
por: Kipps, Thomas J.
Publicado: (2022)

RITUXIMAB IN COMBINATION WITH HIGH DOSE METHYLPREDNISOLONE FOR THE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA
por: Castro, Januario E., et al.
Publicado: (2009)

Relation of Gene Expression Phenotype to Immunoglobulin Mutation Genotype in B Cell Chronic Lymphocytic Leukemia
por: Rosenwald, Andreas, et al.
Publicado: (2001)

Subclonal evolution involving SF3B1 mutations in chronic lymphocytic leukemia
por: Schwaederlé, M, et al.
Publicado: (2013)

Inhibition of chemotherapy resistant breast cancer stem cells by a ROR1 specific antibody
por: Zhang, Suping, et al.
Publicado: (2019)

ROR2 receptor promotes the migration of osteosarcoma cells in response to Wnt5a
por: Dai, Bin, et al.
Publicado: (2017)

IGHV1-69-Encoded Antibodies Expressed in Chronic Lymphocytic Leukemia React with Malondialdehyde–Acetaldehyde Adduct, an Immunodominant Oxidation-Specific Epitope
por: Que, Xuchu, et al.
Publicado: (2013)

Sirt1 Regulates Corneal Epithelial Migration by Deacetylating Cortactin
por: Lin, Yong, et al.
Publicado: (2022)

B-cell Receptor Signaling Induced Metabolic Alterations in Chronic Lymphocytic Leukemia Can Be Partially Bypassed by TP53 Abnormalities
por: Kluckova, Katarina, et al.
Publicado: (2022)

Cortactin function in invadopodia
por: Jeannot, Pauline, et al.
Publicado: (2017)

High cortactin expression in B-cell acute lymphoblastic leukemia is associated with increased transendothelial migration and bone marrow relapse
por: Velázquez-Avila, Martha, et al.
Publicado: (2018)

WNT5a-ROR Signaling Is Essential for Alveologenesis
por: Li, Changgong, et al.
Publicado: (2020)

Role of Cortactin Homolog HS1 in Transendothelial Migration of Natural Killer Cells
por: Mukherjee, Suranjana, et al.
Publicado: (2015)

Migration and invasion is inhibited by silencing ROR1 and ROR2 in chemoresistant ovarian cancer
por: Henry, C E, et al.
Publicado: (2016)

The Tyrosine Kinase Receptor ROR1 Is Constitutively Phosphorylated in Chronic Lymphocytic Leukemia (CLL) Cells
por: Hojjat-Farsangi, Mohammad, et al.
Publicado: (2013)

Spontaneous Immunity Against the Receptor Tyrosine Kinase ROR1 in Patients with Chronic Lymphocytic Leukemia
por: Hojjat-Farsangi, Mohammad, et al.
Publicado: (2015)

Cortactin in Epithelial–Mesenchymal Transition
por: Ji, Rong, et al.
Publicado: (2020)

ROR1 Is Expressed in Human Breast Cancer and Associated with Enhanced Tumor-Cell Growth
por: Zhang, Suping, et al.
Publicado: (2012)

The WNT/ROR Pathway in Cancer: From Signaling to Therapeutic Intervention
por: Menck, Kerstin, et al.
Publicado: (2021)

Ethacrynic Acid Exhibits Selective Toxicity to Chronic Lymphocytic Leukemia Cells by Inhibition of the Wnt/β-Catenin Pathway
por: Lu, Desheng, et al.
Publicado: (2009)

Correction to: Migration and invasion is inhibited by silencing ROR1 and ROR2 in chemoresistant ovarian cancer
por: Henry, C. E., et al.
Publicado: (2022)

Sleeping Beauty Transposition of Chimeric Antigen Receptors Targeting Receptor Tyrosine Kinase-Like Orphan Receptor-1 (ROR1) into Diverse Memory T-Cell Populations
por: Deniger, Drew C., et al.
Publicado: (2015)

Hax-1 is required for Rac1-Cortactin interaction and ovarian carcinoma cell migration
por: Gomathinayagam, Rohini, et al.
Publicado: (2014)

Filopodia formation mediated by receptor tyrosine kinase Ror2 is required for Wnt5a-induced cell migration
por: Nishita, Michiru, et al.
Publicado: (2006)

Cortactin enhances exosome secretion without altering cargo
por: Gangoda, Lahiru, et al.
Publicado: (2016)

Somatic MED12 mutations are associated with poor prognosis markers in chronic lymphocytic leukemia
por: Kämpjärvi, Kati, et al.
Publicado: (2014)

Leukemia-cell proliferation and disease progression in patients with early stage chronic lymphocytic leukemia
por: Murphy, Elizabeth J., et al.
Publicado: (2017)

Targeting the ROR1 and ROR2 receptors in epithelial ovarian cancer inhibits cell migration and invasion
por: Henry, Claire, et al.
Publicado: (2015)

Cortactin and phagocytosis in isolated Sertoli cells
por: Wolski, Katja M, et al.
Publicado: (2005)

Cortactin in Lung Cell Function and Disease
por: Bandela, Mounica, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hj4295k5aki3qc2lgvdiostgfu